Tumor-infiltrating lymphocytes contain higher numbers of type 1 cytokine expressors and DR+ T cells compared with lymphocytes from tumor draining lymph nodes and peripheral blood in patients with cancer of the uterine cervix

Gynecologic Oncology

Volumn 81, Issue 3, 2001, Pages 424-432

  Santin, Alessandro D ^a,b   Ravaggi, Antonella ^a,b   Bellone, Stefania ^a,b   Pecorelli, Sergio ^b   Cannon, Martin ^a   Parham, Groesbeck P ^a   Hermonat, Paul L ^a  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b UNIVERSITY OF BRESCIA   (Italy)

Author keywords

Cervical cancer; IFN ; IL 2; IL 4; Tumor infiltrating lymphocytes

Indexed keywords

CD19 ANTIGEN; CD3 ANTIGEN; CD4 ANTIGEN; CD56 ANTIGEN; CD8 ANTIGEN; CYTOKINE; GAMMA INTERFERON; HLA DR ANTIGEN; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 4;

ADULT; AGED; ARTICLE; CANCER STAGING; CELL COUNT; CELL INFILTRATION; CELL POPULATION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN TISSUE; LYMPHOCYTE; METASTASIS; PHENOTYPE; PRIORITY JOURNAL; T LYMPHOCYTE; TUMOR ASSOCIATED LEUKOCYTE; UTERINE CERVIX CARCINOMA;

EID: 0034985468     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1006/gyno.2001.6200     Document Type: Article

References (37)

1. Epidemiology of cervical cancer: Overview
2. Cancers of the anogenital region in renal transplant recipients. Analysis of 65 cases
3. Rapidly progressing cervical cancer in a patient with human immunodeficiency virus infection
4. Behaviour of mild cervical dysplasia during long term follow-up
5. Role of cell-mediated immunity in spontaneous regression of plane warts
6. Viral warts, herpes simplex, and herpes zoster in patients with secondary immune deficienses and neoplasms
7. Immunization against human papilloma virus type 16 tumor cells with recombinant vaccinia viruses expressing E6 and E7
8. Human papilloma virus type 16 nucleoprotein E7 is a tumor rejection antigen
9. Induction of cytotoxic T lymphocytes specific for a syngeneic tumor expressing the E6 oncoprotein of human papilloma virus type 16
10. Generation of tumor-specific cytolytic T lymphocytes from peripheral blood of cervical cancer patients by in vitro stimulation with a synthetic human papillomavirus type 16 E7 epitope
11. Infiltration of cervical cancer tissue with human papillomavirus-specific cytotoxic T-lymphocytes
12. Human papillomavirus-specific cytotoxic T lymphocytes in patients with cervical intraepithelial neoplasia grade III
13. Induction of human papillomavirus-specific CD4+ and CD8+ lymphocytes by E7 pulsed autologous dendritic cells in patients with HPV16 and 18 positive cervical cancer
14. The stability and reversibility of Th1 and Th2 populations
15. Differentiation of T cell lymphokine gene expression: In vitro acquisition of T cell memory
16. Lymphocyte responses and cytokines
17. Cytokine production patterns in cervical intraepithelial neoplasia: Association with human papillomavirus infection
18. Interleukin 2 production in vitro by peripheral lymphocytes in response to human papillomavirus-derived peptides: Correlation with cervical pathology
19. Prognostic value of intratumoral interferon gamma messanger RNA expression in invasive cervical carcinomas
20. Heterogeneity of intracellular cytokine synthesis at the single cell level in polirized T helper 1 and T helper 2 populations
21. Natural killer cells and cancer
22. Immune function in malignant cervical neoplasia: A multiparameter analysis
23. Development of an immunological staging system to prognosticate disease course in malignant cervical neoplasia
24. Association between poor prognosis in early-stage invasive cervical carcinoma and non-detection of HPV DNA
25. Increased age and mortality associated with cervical carcinomas negative for human papillomavirus RNA
26. Lymphocyte-infiltrated FIGO stage IIB squamous cell carcinoma of the cervix is a prominent factor for disease-free survival
27. Interferon gamma and tumor necrosis factor have a role in tumor regression mediated by murine CD8+ tumor infiltrating lymphocytes
28. Reactivation of murine tumor-infiltrating lymphocytes with solid phase anti-CD3 antibody: In vitro cytokine production is associated with in vivo efficacy
29. The stability and reversibility of Th1 and Th2 populations
30. Differential expression of T cell differentiation antigens and major histocompatibility complex antigens on activated T cells during the cell cycle
31. Down-regulation of CD25 expression on the surface of activated tumor-infiltrating lymphocytes in human cervical carcinoma
32. Expression of CD3-ζ on T-cells in primary cervical carcinoma and in metastasis-positive and -negative pelvic lymph nodes
33. Lymph node metastases; the importance of the micro-environment
34. The host-tumor immune conflict: From immunosuppression to resistance and destruction
35. Decreased expression of signal-transducing ζ chain in peripheral T cells and natural killer cells in patients with cervical cancer
36. Presentation of renal tumor antigens by human dendritic cells activates tumor infiltrating lymphocytes against autologous tumor: Implications for live kidney cancer vaccines